PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
1.01M
No peer data available for comparison.
-202.40K
No peer data available for comparison.
-1.35
No peer data available for comparison.
-35.97M
No peer data available for comparison.
-202.40K
No peer data available for comparison.
37.50M
No peer data available for comparison.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
-50.53%
Worse than INKT's revenue growth rate of -25.00%.
No Data
No DCF data available for this metric in the selected year.
-20.00%
Worse than INKT's ebitda margin of 79.77%.
No Data
No DCF data available for this metric in the selected year.
-20.00%
Worse than INKT's ebit margin of 79.77%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
100.00%
Better than INKT's cash as percentage of revenue of 80.15%.
No Data
No DCF data available for this metric in the selected year.
40.00%
Better than INKT's receivables as percentage of revenue of 80.00%.
No Data
No DCF data available for this metric in the selected year.
40.00%
Better than INKT's inventories as percentage of revenue of 80.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Worse than INKT's payables as percentage of revenue of 80.04%.
No Data
No DCF data available for this metric in the selected year.
-29.43%
Better than INKT's capex as percentage of revenue of -0.00%.
4.99%
Worse than INKT's weighted average cost of capital (wacc) of 4.82%.
5.02%
Worse than INKT's cost of equity of 5.00%.
4.08%
Worse than INKT's cost of debt of 4.06%.
-0.23
Better than INKT's beta of 0.16.
30.07M
Worse than INKT's diluted shares outstanding of 3.77M.
1.57M
Better than INKT's total debt of 4.92M.
49.31M
Better than INKT's total equity of 28.26M.
50.89M
Better than INKT's total capital of 33.19M.
3.09%
Better than INKT's debt weighting of 14.84%.
96.91%
Better than INKT's equity weighting of 85.16%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
2.00%
Equal to INKT's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than INKT's net debt of 347.57K.
71.33M
Better than INKT's equity value of -2.95M.
2.37
Better than INKT's equity value per share of -0.78.